Levofloxacin 0.5% Ophthalmic Solution A Review of its Use in the Treatment of External Ocular Infections and in Intraocular Surgery

被引:22
|
作者
Keating, Gillian M. [1 ]
机构
[1] Wolters Kluwer Hlth Adis, Auckland 0754, New Zealand
关键词
Levofloxacin; bacterial conjunctivitis; external ocular infections; intraocular surgery; pharmacodynamics; pharmacokinetics; therapeutic use; tolerability; IN-VITRO SUSCEPTIBILITIES; BACTERIAL CONJUNCTIVITIS; AQUEOUS-HUMOR; FLUOROQUINOLONE RESISTANCE; MANAGEMENT STRATEGIES; CORNEAL PENETRATION; CLINICAL-TRIAL; PHASE-III; OFLOXACIN; CIPROFLOXACIN;
D O I
10.2165/00003495-200969090-00009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Levofloxacin 0.5% ophthalmic solution (Cravit (R), Quixin (R), Oftaquix (R)) has well established efficacy and tolerability in the treatment of external ocular infections. Levofloxacin 0.5% ophthalmic solution was generally more effective than ofloxacin 0.3% ophthalmic solution in the treatment of external ocular infections, and noninferiority was seen between levofloxacin 0.5% ophthalmic solution and both moxifloxacin 0.5% and tosufloxacin 0.3% ophthalmic solutions in the treatment of bacterial conjunctivitis. Although levofloxacin 0.5% ophthalmic solution administered in the hour prior to surgery did not reduce the incidence of endophthalmitis in patients undergoing intraocular surgery, additional data are needed to examine an optimal preoperative regimen of this antibacterial; preoperative levofloxacin 0.5% ophthalmic solution plus an iodine eyewash reduced positive culture rates in patients undergoing intraocular surgery. Levofloxacin 0.5% ophthalmic solution was well tolerated in the treatment of external ocular infections. Thus, levofloxacin 0.5% ophthalmic solution remains an important option in the treatment of bacterial conjunctivitis and other external ocular infections, as well as for perioperative use.
引用
收藏
页码:1267 / 1286
页数:20
相关论文
共 50 条
  • [21] A phase III, placebo controlled clinical trial of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis
    Hwang, DG
    Schanzlin, DJ
    Rotberg, MH
    Foulks, G
    Raizman, MB
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2003, 87 (08) : 1004 - 1009
  • [22] Update and critical appraisal of the use of topical azithromycin ophthalmic 1% (AzaSite (R)) solution in the treatment of ocular infections
    Utine, Canan Asli
    [J]. CLINICAL OPHTHALMOLOGY, 2011, 5 : 801 - 809
  • [23] Clinical evaluation of bioadhesive ophthalmic drug inserts (BODI®) for the treatment of external ocular infections in dogs
    Baeyens, V
    Felt-Baeyens, O
    Rougier, S
    Pheulpin, S
    Boisramé, B
    Gurny, R
    [J]. JOURNAL OF CONTROLLED RELEASE, 2002, 85 (1-3) : 163 - 168
  • [24] Optimized release of dexamethasone and gentamicin from a soluble ocular insert for the treatment of external ophthalmic infections
    Baeyens, V
    Kaltsatos, V
    Boisrame, B
    Varesio, E
    Veuthey, JL
    Fathi, M
    Balant, LP
    Gex-Fabry, M
    Gurny, R
    [J]. JOURNAL OF CONTROLLED RELEASE, 1998, 52 (1-2) : 215 - 220
  • [25] Review of moxifloxacin hydrochloride ophthalmic solution in the treatment of bacterial eye infections
    Miller, Darlene
    [J]. CLINICAL OPHTHALMOLOGY, 2008, 2 (01): : 77 - 91
  • [26] Brinzolamide ophthalmic suspension: a review of its pharmacology and use in the treatment of open angle glaucoma and ocular hypertension
    Iester, Michele
    [J]. CLINICAL OPHTHALMOLOGY, 2008, 2 (03): : 517 - 523
  • [27] TRIMETHOPRIM POLYMYXIN-B OPHTHALMIC SOLUTION IN TREATMENT OF SURFACE OCULAR BACTERIAL-INFECTIONS
    NOZIK, RA
    SMOLIN, G
    KNOWLTON, G
    AUSTIN, R
    [J]. ANNALS OF OPHTHALMOLOGY, 1985, 17 (12): : 746 - 748
  • [28] Latanoprost ophthalmic solution in the treatment of open angle glaucoma or raised intraocular pressure: a review
    Russo, Andrea
    Riva, Ivano
    Pizzolante, Teodoro
    Noto, Federico
    Quaranta, Luciano
    [J]. CLINICAL OPHTHALMOLOGY, 2008, 2 (04): : 897 - 905
  • [29] Optimization of the Ocular Surface Through Treatment of Ocular Surface Disease Before Ophthalmic Surgery: A Narrative Review
    Barry Schechter
    Francis Mah
    [J]. Ophthalmology and Therapy, 2022, 11 : 1001 - 1015
  • [30] Optimization of the Ocular Surface Through Treatment of Ocular Surface Disease Before Ophthalmic Surgery: A Narrative Review
    Schechter, Barry
    Mah, Francis
    [J]. OPHTHALMOLOGY AND THERAPY, 2022, 11 (03) : 1001 - 1015